Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters. | Int J Mol Sci | 2022 | 35563491 | PubTator, text mining | PubMed |
| Lack of impact of OCTN1 gene polymorphisms on clinical outcomes of gabapentinoids in Pakistani patients with neuropathic pain. | PLoS One | 2022 | 35559956 | PubTator, text mining | PubMed |
| A Comprehensive Review on the Chemical Properties, Plant Sources, Pharmacological Activities, Pharmacokinetic and Toxicological Characteristics of Tetrahydropalmatine. | Front Pharmacol | 2022 | 35559252 | PubTator, text mining | PubMed |
| The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial. | Sci Rep | 2022 | 35538143 | PubTator, text mining | PubMed |
| Cross-species single-cell transcriptomic analysis reveals divergence of cell composition and functions in mammalian ileum epithelium. | Cell Regen | 2022 | 35511361 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis. | Clin Pharmacol Ther | 2022 | 35510337 | PubTator, text mining | PubMed |
| Bendamustine: A review of pharmacology, clinical use and immunological effects (Review). | Oncol Rep | 2022 | 35506458 | PubTator, text mining | PubMed |
| PF-07321332 (Nirmatrelvir) does not interact with human ENT1 or ENT2: Implications for COVID-19 patients. | Clin Transl Sci | 2022 | 35505633 | PubTator, text mining | PubMed |
| Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma. | Comput Struct Biotechnol J | 2022 | 35495118 | PubTator, text mining | PubMed |
| New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium. | Clin Pharmacol Ther | 2022 | 35488474 | PubTator, text mining | PubMed |
| In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia. | Pharm Res | 2022 | 35484370 | PubTator, text mining | PubMed |
| A literature review of liver function test elevations in rifampin drug-drug interaction studies. | Clin Transl Sci | 2022 | 35470578 | PubTator, text mining | PubMed |
| Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1. | J Biol Chem | 2022 | 35469921 | Swiss-Prot, curated | PubMed |
| Programmed Cell Death-Dependent Host Defense in Ocular Herpes Simplex Virus Infection. | Front Microbiol | 2022 | 35464953 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment. | Front Oncol | 2022 | 35463320 | PubTator, text mining | PubMed |
| OAT10/SLC22A13 Acts as a Renal Urate Re-Absorber: Clinico-Genetic and Functional Analyses With Pharmacological Impacts. | Front Pharmacol | 2022 | 35462902 | PubTator, text mining | PubMed |
| Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases. | Molecules | 2022 | 35458666 | PubTator, text mining | PubMed |
| Toxicokinetics of β-Amanitin in Mice and In Vitro Drug-Drug Interaction Potential. | Pharmaceutics | 2022 | 35456608 | PubTator, text mining | PubMed |
| The Role of SLC22A1 and Genomic Ancestry on Toxicity during Treatment in Children with Acute Lymphoblastic Leukemia of the Amazon Region. | Genes (Basel) | 2022 | 35456416 | PubTator, text mining | PubMed |
| Membrane Transporters and Carriers in Human Seminal Vesicles. | J Clin Med | 2022 | 35456310 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=32